🔎 Trials Near Me

Utama › Limfoma Hodgkin › California

Kajian klinikal Limfoma Hodgkin di California

15 kajian untuk Limfoma Hodgkin sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

  • City of Hope Cancer Center (Data Collection Only), Duarte
  • Stanford University Medical Center, Stanford
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT03618550

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • City of Hope, Duarte
Mengambil pesertaFasa 1
Umur 18 hingga 100 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Duarte
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06137144

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Davis Comprehensive Cancer Center, Sacramento
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT05272384

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

  • University of California Davis, Davis
  • University of California San Francisco-Fresno, Fresno
  • University of California Irvine, Irvine
  • dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07021989

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07020533

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06580002

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  • Stanford University - (Stanford Cancer Institute), Stanford
Mengambil pesertaFasa 3
Umur 16 hingga 69 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT04685616

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • City of Hope, Duarte
  • Children's Hospital of Los Angeles, Glendale
  • Scripps Green Hospital, La Jolla
  • dan 8 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

  • Stanford University Medical Center, Palo Alto
Mengambil pesertaKajian pemerhatian
Umur 8 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06098430

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

  • City of Hope National Medical Center, Duarte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06915246

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT06059391

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

  • Stanford University School of Medicine, Stanford
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Dis 2025 · NCT00398177

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • City of Hope Medical Center, Duarte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Dis 2025 · NCT04871607

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
Mengambil pesertaFasa 1
Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.